发明名称 |
Combination formulation of two antiviral compounds |
摘要 |
<p>In the present application disclosed are pharmaceutical compositions having an effective amount of substantially amorphous ledipasvir and an effective amount of substantially crystalline sofosbuvir.The compositions proposed are effective in the treatment of hepatitis C without exhibiting a negative food effect.</p> |
申请公布号 |
MD20150080(A2) |
申请公布日期 |
2015.12.31 |
申请号 |
MD20150000080 |
申请日期 |
2014.01.30 |
申请人 |
GILEAD PHARMASSET LLC. |
发明人 |
CHAL BEN;MOGALIAN ERIK;PAKDAMAN ROWCHANAK;OLIYAI REZA;STEFANIDIS DIMITRIOS;ZIA VAHID |
分类号 |
A61K9/16;A61K9/20;A61K31/501;A61K31/513;A61P1/16;A61P31/12 |
主分类号 |
A61K9/16 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|